Home
Wilmington PharmaTech

Wilmington PharmaTech Market Share Analysis for June 2026

FDA inspected US facilities supporting complex small molecule and HPAPI programs, with integrated laboratories, GMP manufacturing, and capacity for future growth.

Industry: N/A

Domainwilmingtonpharmatech.com

Year Founded2003

Employees51 - 200

Annual Revenue$15M - $25M

Wilmington PharmaTech

Wilmington PharmaTech (including company regionals)

wilmingtonpharmatech.com

See more website traffic and engagement information

Wilmington PharmaTech Revenue up to June 2026 is 15M - 25M

revenue generated by Wilmington PharmaTech top domains

Wilmington PharmaTech top domains revenue over 3 years

Revenue for Wilmington PharmaTech top domains

wilmingtonpharmatech.com15M - 25M

See more with Sales Intelligence

Total visits to Wilmington PharmaTech's top domains

Understand Wilmington PharmaTech market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

wilmingtonpharmatech.com2.1K

See more with Sales Intelligence

Avg. visit duration in Wilmington PharmaTech's top domains

Analyze Wilmington PharmaTech engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

wilmingtonpharmatech.com00:01:30

See more with Sales Intelligence

Avg. pageviews on Wilmington PharmaTech's top domains

See how Wilmington PharmaTech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

wilmingtonpharmatech.com1.92

See more with Sales Intelligence

Wilmington PharmaTech top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Wilmington PharmaTech

These are the website technologies, by industry, used by Wilmington PharmaTech top domains

Widget (6)

Twemoji

Advertising (4)

DoubleClick

Conversion & Analytics (3)

Google Analytics

Payment & Currencies (3)

Visa

More Technologies

9

See all

News & Signals from Wilmington PharmaTech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsWilmington PharmaTech Company LLC invests into assets: cGMP API manufacturing capacity in United States, Northern America, Americas."Over the past decade, Wilmington has been among the few companies to actively invest in cGMP API manufacturing capacity in the U.S., including the recent addition of two new commercial-scale high-potency API suites," said Hui-Yin "Harry" Li, Ph.D., Founder and CEO of Wilmington PharmaTech.